BMY Bristol-Myers Squibb Company
BMY Stock Analysis Overview
What this means: InvestorsObserver gives Bristol-Myers Squibb Company (BMY) an overall rank of 39, which is below average. Bristol-Myers Squibb Company is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 39 means that 61% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
BMY Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
BMY Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
BMY Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
BMY Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
BMY Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
BMY Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
BMY Stock Analysis Overview
What this means: InvestorsObserver gives Bristol-Myers Squibb Company (BMY) an overall rank of 39, which is below average. Bristol-Myers Squibb Company is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 39 means that 61% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.